The domestic market of anti lung cancer drugs has become a blue ocean with various enterprises
-
Last Update: 2017-08-31
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
China's incidence rate of lung cancer is increasing Lung cancer has become the leading cancer incidence rate in China, ranking 2017-08-31 and August 31st At present, the domestic anti lung cancer drug market has become a blue ocean, enterprises have layout, trying to take a share On the one hand, with the release of CFDA's decision on adjusting the registration and management of imported drugs (Draft for comments), the regulatory authorities simplified a number of restrictions on the entry of overseas unlisted new drugs into China On the other hand, the first imitated products of Chinese enterprises began to appear on the market, and there have been four cases of smoke in this market!
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
